Ask Industry Anything (Again) – Tuesday 28th November 2017
BioMelbourne Network – Bringing industry and academia together! In November 2016, we launched “Ask Industry Anything” a new event which gave tables of students and researchers from leading academic organisations the opportunity to ask leaders from the biotechnology,…
Hydrix & Panorama
Today it was announced that Panorama Synergy Limited (ASX: PSY) has entered into an agreement to fully acquire Hydrix through an asset purchase agreement. This is an exciting development for both companies with the Merged Group at the…
BTF – Medical technology investment to improve lives
The Turnbull Government will fund three medical breakthroughs to help people with severe disabilities walk again and support thousands of Australians facing crippling chronic back pain.A total of $13.3 million will be invested into high potential Australian innovations…
Victorian patients with frontotemporal dementia to trial new drug
IN a world-first trial, Victorians with a devastating form of dementia that strikes in middle age will be given a drug aimed at slowing the disease. Thousands of Australians have the condition, which causes changes in personality and…
Discovery Award to support new test for sepsis
Burnet Institute’s Global Health Diagnostics Laboratory has been awarded a prestigious Longitude Prize Discovery Award to facilitate the development of a laboratory-based sepsis assay into a point-of-care test. The award will also support the Laboratory’s bid for a…
BioMelbourne Network has appointed Lusia Guthrie to the BioMelbourne Network’s Board of Directors as of September 2017
With over 35 years in pharmaceutical and bioscience industries, Lusia Guthrie is an experienced executive and medtech entrepreneur, with strong leadership skills and international industry networks. She started her career as a Medical Laboratory Scientist before joining the…
Attention all Victorians attending AusBiotech 2017 in Adelaide
The Victorian Government will be hosting a stand in the Exhibition Hall for the duration of the AusBiotech Conference, promoting Victoria as a leading global location for biotechnology. You are encouraged to drop by the stand to connect…
CSL Completes Transaction to Acquire a Majority Stake in Chinese Plasma Fractionator
CSL Limited (ASX:CSL; USOTC:CSLLY) today announced that it has closed a joint venture transaction with Humanwell Healthcare Group Co. Ltd. (Humanwell; Shanghai exchange: 600079) to acquire a majority stake in plasma-derived therapies manufacturer Wuhan Zhong Yuan Rui De Biological…
Global Connections Fund Bridging Grant Awardees 2017
The Global Connections Fund is an initiative of the Australian Government’s National Innovation and Science Agenda (NISA) funded by the Department of Industry, Innovation and Science. You can see Bridging Grant Awardees here
Positive Data from Cynata MSCs in Second Preclinical Asthma Study
Positive Data from Cynata MSCs in Second Preclinical Asthma Study • Clear efficacy data for Cynata’s proprietary Cymerus™ MSCs in second preclinical study in a clinically-relevant model of asthma • Cymerus MSCs caused significantly greater reduction of airway…
Regenerative Medicine Industry Interface – a new industry collaboration in Victoria
Announcing RMI2 The Regenerative Medicine Industry Interface Regenerative Medicine An emerging field of medical science, regenerative medicine incorporates the use of cells, factors, and other biological building blocks, along with bioengineered materials and technologies for widespread clinical applications.…
Victorian medical emergency company Medical Developments International emerges as global leader
A Victorian emergency medicine company has risen to become a global leader, thanks to its range of respiratory medications. Offering new devices for asthma and chronic obstructive pulmonary disease (COPD), Medical Developments International (MDI), is turning its attention…
